Free Trial

Synthomer (LON:SYNT) Hits New 52-Week Low - Here's Why

Synthomer logo with Basic Materials background

Key Points

  • Synthomer plc's share price reached a new 52-week low of GBX 57.40 ($0.78) during trading, with current shares priced at GBX 59.30 ($0.80).
  • Equities analysts have mostly rated Synthomer as a "hold," with price targets ranging from GBX 80 to GBX 140, indicating uncertainty in its future performance.
  • The company reported a negative EPS of GBX (5.40) and anticipates an EPS of 12.96 for the current fiscal year, signaling ongoing financial challenges.
  • Five stocks we like better than Synthomer.

Synthomer plc (LON:SYNT - Get Free Report)'s stock price reached a new 52-week low on Tuesday . The stock traded as low as GBX 57.40 ($0.78) and last traded at GBX 59.30 ($0.80), with a volume of 2084620 shares changing hands. The stock had previously closed at GBX 59.10 ($0.80).

Wall Street Analyst Weigh In

Several analysts recently weighed in on SYNT shares. Berenberg Bank cut their price target on shares of Synthomer from GBX 120 to GBX 80 and set a "hold" rating on the stock in a report on Wednesday, August 6th. Jefferies Financial Group reissued a "hold" rating and issued a GBX 100 target price on shares of Synthomer in a research report on Tuesday, August 5th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Synthomer from GBX 140 to GBX 115 and set a "hold" rating for the company in a research report on Wednesday, July 30th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of GBX 142.50.

View Our Latest Research Report on SYNT

Synthomer Price Performance

The stock has a market cap of £98.08 million, a PE ratio of -117.42, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The company has a debt-to-equity ratio of 78.27, a quick ratio of 0.97 and a current ratio of 1.90. The company's 50-day moving average price is GBX 75.85 and its 200 day moving average price is GBX 95.11.

Synthomer (LON:SYNT - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported GBX (5.40) EPS for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. As a group, analysts forecast that Synthomer plc will post 12.962963 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Lily Liu acquired 20,000 shares of the business's stock in a transaction that occurred on Tuesday, August 5th. The stock was bought at an average cost of GBX 64 per share, for a total transaction of £12,800. Also, insider Uwe Halder acquired 25,000 shares of the business's stock in a transaction that occurred on Thursday, August 7th. The shares were bought at an average price of GBX 64 per share, with a total value of £16,000. In the last quarter, insiders have purchased 124,149 shares of company stock valued at $8,701,965. Insiders own 4.99% of the company's stock.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

Featured Stories

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.